Akorn Inc (AKRX.O)
20 Sep 2017
BOSTON U.S. prosecutors have identified Insys Therapeutics Inc's billionaire founder as an unindicted co-conspirator in a case accusing six former executives and managers of participating in a scheme that involved bribing doctors to prescribe a fentanyl-based drug, according to a court document.
* At yesterday's special meeting, shareholders of Akorn, Inc., have approved merger agreement with fresenius kabi, with 83.9 percent of outstanding shares being voted in favour of transaction. Source text for Eikon: Further company coverage:
* Akorn shareholders vote to approve merger agreement with Fresenius Kabi
Mallinckrodt Plc is exploring a sale of its generic drug unit, in a deal that could fetch as much as $2 billion and help pivot the specialty pharmaceutical maker toward higher-margin branded drugs, according to people familiar with the matter.
FRANKFURT, May 12 The head of German healthcare group Fresenius SE said he would abstain from the takeover market for now, after striking three deals worth billions of euros in total since taking over less than a year ago.
FRANKFURT German healthcare group Fresenius on Wednesday toned up its earnings guidance for the year as demand for recently launched generic infusion drugs continued to grow at higher-than-expected rates.
FRANKFURT, May 3 German healthcare group Fresenius SE & Co KGaA on Wednesday lifted its guidance on strong demand in the United States for its generic infusion drugs.
April 25 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Tuesday:
FRANKFURT German healthcare group Fresenius SE & Co KGaA has stepped up its dealmaking, agreeing to buy U.S. generic drugmaker Akorn Inc for $4.75 billion (4.37 billion euros) and the biosimilars arm of Germany's Merck KGaA.
* Fresenius shares up almost 1 percent (Adds advisers, shares, background, CEO, analyst comments)
|Novartis AG (NOVN.S)||CHF82.90||+0.15|
|Pfizer Limited (PFIZ.NS)||Rs1,770.30||--|
|Hikma Pharmaceuticals Plc (HIK.L)||1,135.00||-15.00|
|Fresenius Kabi Oncology Ltd (FRES.M3)||--||--|
|Mylan NV (MYL.OQ)||$31.39||+0.41|
|Taro Pharmaceutical Industries Ltd. (TARO.N)||$107.17||+1.01|
|Valeant Pharmaceuticals Intl Inc (VRX.TO)||$17.33||+0.43|
|Johnson & Johnson (JNJ.N)||$133.22||-2.00|